EXPRESS SCRIPTS HLDG CO - COM (ESRX)

CUSIP: 30219G108

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
631,886,962
Share change
-1,412,806
Total reported value
$54,818,435,218
Put/Call ratio
88%
Price per share
$86.77
Number of holders
1,189
Value change
-$109,336,780
Number of buys
494
Number of sells
546

Security key

30219G108

Report period

Q1 2015

Institutions

1,189

Top holders

10

Ownership snapshot

Top shareholders of ESRX - EXPRESS SCRIPTS HLDG CO - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2015

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1,189
Shares
631,886,962
Rows loaded
1,190
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders
1,170
Q1 2015 holders
1,189
Holder diff
19
Investor Q4 2014 Shares Q1 2015 Shares Share Diff Share Chg % Q4 2014 value Q1 2015 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .